NCT04662086View on ClinicalTrials.gov

COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Master Protocol

PHASE2CompletedINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

April 23, 2021

Primary Completion Date

May 3, 2022

Study Completion Date

February 2, 2023

Conditions
Covid19
Interventions
DRUG

Acebilustat

100 mg capsule administered orally once daily

DRUG

Camostat

200 mg (2 x 100 mg tablet) administered orally four times daily (800 mg total daily dose).

Trial Locations (2)

94305

Stanford University, Stanford

94588

ValleyCare Medical Center, Pleasanton

All Listed Sponsors
lead

Stanford University

OTHER